News & Opinionn


Cutting the Use of Antipsychotics in Nursing Homes


By Jonathan Block

April 24, 2017

Cutting the Use of Antipsychotics in Nursing Homes

Use of antipsychotic drugs in nursing home can be cut significantly by training staff to recognize certain behavior by elderly patients as a sign of unmet needs.

Researchers in Massachusetts examined how a communication training program known as “Oasis” designed for nursing home staff impacted off-label antipsychotic use. Off-label prescribing of antipsychotics for nursing home patients with dementia is common, even though the drugs are not that effective at controlling behavioral symptoms and they come with an increased risk of stroke and death.

The study compared off-label prescribing use in 93 nursing homes enrolled in Oasis to 831 not involved in the program. In the Oasis facilities, antipsychotic prescriptions were reduced to 27% from 34% after just 9 months, the researchers reported in JAMA Internal Medicine. At the other nursing homes, there was only a 4% drop over the same period.


We need scientists to research marijuana - but they can't because the DEA calls it a Schedule I drug. Join us in asking the DEA to name it a Schedule II drug so research can begin. Sign the petition | Learn more

“The Oasis program asks nursing staff to create care plans that include what residents can do, shifting away from the model that focuses on what they can’t do,” lead study author Jennifer Tjia, MD, an associate professor of quantitative health sciences at the University of Massachusetts School of Medicine said in a statement. “This is a fundamental shift in how to think about caring for persons with dementia and we showed that it is effective.”

Jonathan Block

Jonathan Block

Jonathan Block is MedShadow’s content editor. He has previously worked for Psychiatry Advisor, Modern Healthcare, Health Reform Week and The Pink Sheet.

Average: 0


Last updated: April 24, 2017